Morgan Stanley’s Neon Therapeutics, Inc. Common Stock NTGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-58,904
| Closed | -$156K | – | 6884 |
|
|
2020
Q1 | $156K | Sell |
58,904
-14,550
| -20% | -$38.5K | ﹤0.01% | 4980 |
|
|
2019
Q4 | $86K | Buy |
73,454
+540
| +0.7% | +$632 | ﹤0.01% | 5699 |
|
|
2019
Q3 | $126K | Buy |
72,914
+32,392
| +80% | +$56K | ﹤0.01% | 5359 |
|
|
2019
Q2 | $192K | Buy |
40,522
+3,939
| +11% | +$18.7K | ﹤0.01% | 5045 |
|
|
2019
Q1 | $236K | Sell |
36,583
-12,479
| -25% | -$80.5K | ﹤0.01% | 4972 |
|
|
2018
Q4 | $247K | Buy |
49,062
+34,659
| +241% | +$174K | ﹤0.01% | 5195 |
|
|
2018
Q3 | $123K | Buy |
14,403
+11,099
| +336% | +$94.8K | ﹤0.01% | 5628 |
|
|
2018
Q2 | $42K | Buy |
+3,304
| New | +$42K | ﹤0.01% | 5953 |
|